Articles from Rocket Doctor AI Inc.

Toronto, ON, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Rocket Doctor AI Inc. (CSE: AIDR, OTC: AIRDF, Frankfurt: 939) (“Rocket Doctor AI”) today announced that its wholly-owned digital health platform and marketplace, Rocket Doctor Inc., is receiving advisory services and funding of up to $75,000 from the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP) to develop secure communications functionality, and funding of up to $25,000 from the CanExport SMEs program to accelerate product innovation and U.S. market growth.

New York, NY, Oct. 08, 2025 (GLOBE NEWSWIRE) -- Rocket Doctor AI Inc. (CSE: AIDR, OTC: AIRDF, Frankfurt: 939) (“Rocket Doctor AI”) today announced that doctors using its wholly-owned digital health platform and marketplace, Rocket Doctor Inc., are now in-network with half a dozen major insurance companies across the United States. These agreements provide access to Rocket Doctor’s services for more than 7 million patients across California and New York.

Vancouver, BC, Oct. 07, 2025 (GLOBE NEWSWIRE) -- Rocket Doctor AI Inc. (CSE: AIDR, OTC: AIRDF, Frankfurt: 939) (“Rocket Doctor AI”) announces that, due to the Canada Postal Strike, there is a delay in the mailing of the Company’s proxy circular and related documents pertaining to the Company’s Annual General Meeting (the “Meeting”) of the shareholders to be held on Wednesday, October 22, 2025 at the hour of 10:00 a.m. (Pacific Time) at the offices of McMillan LLP, Suite 1500 – 1055 West Georgia Street, Vancouver, British Columbia.

Toronto, ON, Oct. 02, 2025 (GLOBE NEWSWIRE) -- Rocket Doctor AI Inc. (CSE: AIDR, OTC: AIRDF, Frankfurt: 939) (“Rocket Doctor AI”) today announced that its wholly-owned digital health platform and marketplace, Rocket Doctor Inc., has entered into a reseller agreement with Remmie, Inc., the Seattle-based medical device company behind the Remmie 4, an FDA and Health Canada MDEL cleared USB-smart otoscope designed for easy, at-home ear exams.

TORONTO, Ontario, Sept. 29, 2025 (GLOBE NEWSWIRE) -- Rocket Doctor AI Inc. (CSE: AIDR, OTC: AIRDF, Frankfurt: 939) (“Rocket Doctor AI”) a healthcare technology company focused on delivering physician-built, AI-powered solutions designed to make high-quality healthcare accessible throughout the entire patient journey, is pleased to announce its participation at the upcoming CANTech Letter Investment Conference on Thursday, October 9, 2025, in Toronto, Ontario. Rocket Doctor AI’s CEO, Dr. Essam Hamza, and Founder & CEO of Rocket Doctor Inc., Dr. William Cherniak, will present an overview of the company’s platform, solutions, recent milestones, and growth strategy.2025 CANTech Letter Conference

Vancouver, British Columbia, Sept. 26, 2025 (GLOBE NEWSWIRE) -- Rocket Doctor AI Inc. (the “Company” or “Rocket Doctor AI”) (CSE: AIDR, OTC: AIRDF, Frankfurt: 939) announces that it has filed a prospectus supplement dated September 22, 2025 (the “Prospectus Supplement”) to its short form base shelf prospectus dated June 10, 2024 (the “Shelf Prospectus”) to qualify the distribution of securities underlying 3,677,400 special warrants (the “Special Warrants”) issued by the Company on August 21, 2025 (the “Offering”).

Baltimore, MD, Sept. 23, 2025 (GLOBE NEWSWIRE) -- Rocket Doctor AI Inc. (CSE: AIDR, OTC: AIRDF, Frankfurt: 939) (“Rocket Doctor AI”) today announced that doctors using its wholly-owned digital health platform and marketplace, Rocket Doctor Inc., are now in-network with Maryland Medicaid and Medicare. This milestone enables Rocket Doctor to begin serving Maryland residents covered under these public insurance programs through in-network access, improving affordability, coverage, and continuity of care.

Toronto, ON, Sept. 09, 2025 (GLOBE NEWSWIRE) -- Rocket Doctor AI Inc. (CSE: AIDR, OTC: AIRDF, Frankfurt: 939) (“Rocket Doctor AI”) today announced that its wholly-owned digital health platform and marketplace, Rocket Doctor Inc., has surpassed a major milestone with the expansion of its pharmacy-based virtual care and diagnostic devices program to 50 independently owned pharmacies across Canada with appointments covered by provincial insurance. 

New York, NY , Sept. 04, 2025 (GLOBE NEWSWIRE) -- Rocket Doctor AI Inc. (CSE: AIDR, OTC: AIRDF, Frankfurt: 939) (“Rocket Doctor AI”) today announced that doctors using its wholly-owned digital health platform and marketplace, Rocket Doctor Inc., are now in-network with Aetna in New York State, having been fully credentialed for Medicare and commercial plans.

Vancouver, British Columbia, Aug. 29, 2025 (GLOBE NEWSWIRE) -- Rocket Doctor AI Inc. (formerly Treatment.com AI Inc.). (the “Company”) (CSE: AIDR; OTC: TREIF; FFA: 939) is pleased to announce its financial results for the second quarter ended June 30, 2025. All financial information is presented in Canadian dollars unless otherwise indicated.

Vancouver, British Columbia, Aug. 22, 2025 (GLOBE NEWSWIRE) -- Rocket Doctor AI Inc (formerly Treatment.com AI Inc.). (the “Company”) (CSE: AIDR; OTC: TREIF; FFA: 939) is pleased to announce that, further to its news release dated 25th July, 2025, it has closed its non-brokered private placement of 3,677,400 special warrants of the Company (each, a “Special Warrant”) at a price of $0.50 per Special Warrant, for aggregate gross proceeds of C$1,838,700 and 4,792,000 units of the Company (each, a “Unit”) at a price of $0.50 per Unit, for aggregate gross proceeds of C$2,396,000 (the “Offering”).